GLP-1 receptor agonists: A new frontier in combating metabolic liver disease complications

IF 6.7 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Alimentary Pharmacology & Therapeutics Pub Date : 2024-09-27 DOI:10.1111/apt.18244

Ayesha Fatima, Ayesha Maryam, Muhammad Salman Nadeem, Kashaf Noor Asmat

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

GLP-1 受体激动剂：防治代谢性肝病并发症的新领域

本文链接至 Elsaid 等人的论文。要查看本文，请访问 https://doi.org/10.1111/apt.17925

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Alimentary Pharmacology & Therapeutics 医学-胃肠肝病学

CiteScore

15.60

自引率

7.90%

发文量

527

审稿时长

3-6 weeks

期刊介绍： Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.

期刊最新文献

Amino Acid Imbalance Is an Independent Factor for Mortality in Patients With Liver Cirrhosis. Letter: Tumour Burden Score for Predicting Extrahepatic Metastasis in Hepatocellular Carcinoma After Curative Resection. Letter: Unlocking the Full Potential of Dietary Therapy in IBD-The Case for Universal Eating Disorder Screening. Letter: Improving the Interpretability and Portability of Tumour Burden Score-Based Prediction of Extrahepatic Progression After Transarterial Chemoembolisation (TACE)-Author's Reply. Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes.